Clinical trials
Completed Obesity trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
216 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 3 |
| 2014 | 7 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 11 |
| 2020 | 12 |
| 2021 | 15 |
| 2022 | 18 |
| 2023 | 28 |
| 2024 | 44 |
| 2025 | 36 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 216 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 10 |
| Eli Lilly and Company | 8 |
| BrightGene Bio-Medical Technology Co., Ltd. | 7 |
| Vincentage Pharma Co., Ltd | 7 |
| Boehringer Ingelheim | 6 |
| Fujian Shengdi Pharmaceutical Co., Ltd. | 6 |
| Shanghai Minwei Biotechnology Co., Ltd | 6 |
| Wecare Probiotics Co., Ltd. | 6 |
| Chendu DIAO Pharmaceutical Group CO., LTD. | 4 |
| Gan and Lee Pharmaceuticals, USA | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 216 |
| Overweight | 117 |
| Diabetes Mellitus, Type 2 | 27 |
| Metabolic Syndrome | 9 |
| Diabetes Mellitus | 8 |
| Weight Loss | 8 |
| Hypertension | 6 |
| Polycystic Ovary Syndrome | 6 |
| Obesity, Abdominal | 5 |
| Cardiovascular Diseases | 4 |
Trials
Showing 1 to 25 of 216. Each trial links to its page on Pharma Observatory.
116 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.